NIGHTSTAR THERAPEUTICS PLC Stock-Based Compensation
NIGHTSTAR THERAPEUTICS PLC reported Stock-Based Compensation of $1.73 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2019-05-10
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $1.73M, a 107.42% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $1.18M, a 65.49% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $959.00K, a 124.07% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $1.21M.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for fiscal 2018 was $4.18M, a 204.52% increase from fiscal 2017.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for fiscal 2017 was $1.37M, a 560.10% increase from fiscal 2016.
- NIGHTSTAR THERAPEUTICS PLC share-based payment arrangement, noncash expense for fiscal 2016 was $208.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-03-31 | $1.73M 10-Q · filed 2019-05-10 | $2.91M derived: sum of 2 quarters · filed 2019-05-10 | $3.87M derived: sum of 3 quarters · filed 2019-05-10 | $5.08M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | $1.18M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $2.13M derived: sum of 2 quarters · filed 2019-03-18 | $3.35M derived: sum of 3 quarters · filed 2019-03-18 | $4.18M 10-K · filed 2019-03-18 |
| 2018-09-30 | $959.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-20 | $2.17M derived: sum of 2 quarters · filed 2018-11-20 | $3.01M 6-K · filed 2018-11-20 | $3.72M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-06-30 | $1.21M derived: 6-K 6 month − 10-Q 3 month · filed 2018-08-15 | $2.05M 6-K · filed 2018-08-15 | $2.76M derived: sum of 3 quarters · filed 2019-05-10 | $3.19M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-03-31 | $836.00K 10-Q · filed 2019-05-10 | $1.55M derived: sum of 2 quarters · filed 2019-05-10 | $1.97M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | $710.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $1.14M derived: sum of 2 quarters · filed 2019-03-18 | $1.37M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $428.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-20 | $663.00K 6-K · filed 2018-11-20 | ||
| 2017-06-30 | $235.00K 6-K · filed 2018-08-15 | |||
| 2016-12-31 | $208.00K 10-K · filed 2019-03-18 | |||
| 2015-12-31 | $112.00K 20-F · filed 2018-04-03 |